We previously showed that the chromatin-modulating cofactor JMJD1C is universally required for the survival of AML cells with different genetic backgrounds (Chen et al., 2015), but how JMJD1C regulates the leukemic programs of various AML cells has been unclear. This evidence concerns the gene JMJD1C and acute myeloid leukemia.